跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVOSIMENDAN ALTAN 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LEVOSIMENDAN ALTAN 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
LEVOSIMENDAN ALTAN 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Altan Pharmaceuticals Sa
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 2, 2021
Approval ID
7d5e2aad8020e0e9
Company
Altan Pharmaceuticals Sa
Type
Standard
Approval Details
Approval Id
7d5e2aad8020e0e9
Drug Cima Aemps Name
LEVOSIMENDAN ALTAN 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number
85993
Holder Company Name
Altan Pharmaceuticals Sa
Marketing Company Name
Altan Pharmaceuticals Sa
Authorization Date
2021-06-02
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
2,5 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Altan Pharmaceuticals Sa
Active Ingredients
LEVOSIMENDAN
2,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 2, 2021
Approval ID
7d5e2aad8020e0e9
Type
Standard
Back to CIMA-AEMPS Approvals